|
| |
DSP
| Contact Details: |
| 27 Concord St |
| Ilion |
| NY |
| 13357 |
| United States of America |
| Tel: | 315 894 1307 |
| Fax: | 315 894 8849 |
| Email: | |
|
Loading...
|
Recent Publications by DSP: |  |
[In Process Citation]
OBJECTIVES: Since 2004, a surveillance system provides counts, almost in... | 21st October, 2009
| Direction de sante publique de l'Agence de la sante et des services
| Can J Public Health. 2009 Mar-Apr;100(2):153-6.
|
Phonetically optimized speaker modeling for robust speaker recognition.
This paper proposes an efficient method to improve speaker recognition... | 11th September, 2009
| Electrical and Electronic Engineering, Yonsei University, 134
| J Acoust Soc Am. 2009 Sep;126(3):EL100-6.
DOI Direct Link |
Computer vision for microscopy diagnosis of malaria.
This paper reviews computer vision and image analysis studies aiming at... | 12th August, 2009
| Applied DSP & VLSI Research Group, University of Westminster, London, UK.
| Malar J. 2009 Jul 13;8:153.
DOI Direct Link |
Heat awareness and response among Montreal residents with chronic cardiac and pulmonary disease.
OBJECTIVES: Persons affected by chronic heart and lung disease risk... | 11th July, 2009
| DSP de Montreal (Public
| Can J Public Health. 2009 May-Jun;100(3):237-40.
|
Genetic testing for multiple endocrine neoplasia type 2.
Multiple endocrine neoplasia type 2 (MEN 2) represents a complex autosomal... | 25th April, 2009
| C.I. Parhon National Institute of Endocrinology , Bucharest, Romania.
| Rom J Intern Med. 2008;46(2):159-63.
|
→View more DSP research publications. |
Press Releases on DSP:
|
 |
| NeurogesX Reports Third Quarter 2009 Results |
6th November, 2009 |
NeurogesX |
-- Appointed Bradford S. Goodwin to board as director and Audit Committee
chairman
Upcoming 2009 Milestones:
-- FDA PDUFA date November 16, 2009 for Qutenza NDA to manage pain
|
| NeurogesX Expands Commercial Operations Leadership Team |
5th November, 2009 |
NeurogesX |
-- Timothy Arendt has been named Vice President Sales. He will implement
and manage the U.S. specialty sales force for Qutenza(TM).
-- Amy C. Cavers has joined NeurogesX as
|
| NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results |
30th October, 2009 |
NeurogesX, Inc. |
SAN MATEO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today
|
| NeurogesX to Present at Two November Conferences |
29th October, 2009 |
NeurogesX, Inc. |
SAN MATEO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced
|
| NeurogesX to Present at JMP Securities Healthcare Focus Conference |
1st October, 2009 |
NeurogesX |
SAN MATEO, Calif., Oct. 1 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 12 individuals from DSP using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 189 times since April 2007, the link to the organisation's website has been followed 0 times Search for more companies in Ilion Search for more companies in NY This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for DSP |
